(PR-inside.com) TRENTON, ME -- (Marketwire) -- 04/28/11 -- Bar Harbor BioTechnology, Inc. (BHB), developer of genetic risk assessment testing and Clinical Reference Laboratory, Inc. (CRL), provider of laboratory testing services in molecular diagnostics and clinical trials, have reached an agreement to work together in the development of new genetic diagnostic tests. The first project under the new agreement involves the continued development of BHB's new genetic-based risk assessment test for colorectal cancer with clinical validation support provided by CRL's CLIA-certified laboratory services. The new arrangement will give CRL and BHB the opportunity to combine BHB's bioinformatics and qPCR assay development ..
More...
More...